FIH Trial Trends: How far we’ve come and where we’re going with PK data

Monday, November 6, 2023 @ 11am – 12pm EST

Join this webinar to gain insights into PK in FIH trials and how the data is essential for driving innovation and improving patient outcomes.

0

days left

About this webinar

Discover an informative webinar delving into pharmacokinetics (PK) in first-in-human (FIH) studies and how it optimizes the data points in clinical trials. In the ever-evolving landscape of pharmaceutical research, it’s crucial to keep a close eye on the changes in PK in FIH trials over the past decade. These changes hold valuable insights that can significantly impact the success of clinical studies.

The influence of PK data on clinical study decision-making cannot be overstated; it serves as a cornerstone in shaping the direction of drug development. Furthermore, comprehending how PK data gathered in FIH trials can be leveraged to optimize data collection in long-term patient studies is paramount. It also enables researchers to streamline the data points collected, enhancing efficiency and reducing the burden on patients while ensuring that the clinical trial remains robust and informative.

Join this webinar to gain insights into PK in FIH trials and how the data is essential for driving innovation and improving patient outcomes.

The speakers are Sherilyn Adcock, RPh, PhD, Chief Scientific Officer, Early Phase Development and Jeffrey G. Stark, PhD, Senior Director, Head of Pharmacokinetics.

Date

Monday
November 6, 2023

Dr. Sherilyn Adcock

Chief Scientific Officer, Early Phase Development

Jeffrey G. Stark, PhD

Senior Director, Head of Pharmacokinetics

Upcoming events

Outsourcing Clinical Trials Southeast

Durham, North Carolina
Learn More
3 days left

Chief Medical Officer Summit

Boston, Massachusetts
Learn More
4 days left

Countdown to Crunch Time: How Early and Continual Regulatory Engagement Leads to Regulatory and Commercial Success

Webinar
Learn More
9 days left